1. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients
   Jing Chen et al, 2014, BMC Cancer CrossRef
2. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
   Wenli Xie et al, 2019, Cancer Medicine CrossRef
3. Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review
   Sander Bach et al, 2019, JNCI Cancer Spectrum CrossRef
4. Colorectal cancer: using blood samples and tumor tissue to detectK-rasmutations
   Yang Li et al, 2015, Expert Review of Anticancer Therapy CrossRef
5. Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers
   Qiwei Yang et al, 2018, Frontiers in Oncology CrossRef
6. Mutations of key driver genes in colorectal cancer progression and metastasis
   Dongdong Huang et al, 2018, Cancer and Metastasis Reviews CrossRef
7. Circulating Tumor DNA is Effective for Detection of KRAS Mutation in Colorectal Cancer: A Meta-Analysis
   Min Tang et al, 2017, The International Journal of Biological Markers CrossRef
8. VE1 immunohistochemical detection of the BRAF V600E mutation in thyroid carcinoma: a review of its usefulness and limitations
   Jong-In Na et al, 2015, Virchows Archiv CrossRef
9. Serum-Based KRASG12/G13 Mutation Detection Using Droplet Digital PCR: Clinical Implications and Limitations in Colorectal Adenocarcinoma With Tumor Heterogeneity
   Ju Seok Kim et al, 2021, Frontiers in Oncology CrossRef